The life sciences supplier posted 0.5% sales growth, $142.8 million in free cash flow and lifted its organic revenue and adjusted EPS guidance for fiscal 2026.
Avantor reported better-than-expected second-quarter 2026 results and increased its fiscal 2026 outlook, pointing to stronger execution under its Revival program and faster-than-expected improvement in VWR Distribution & Services. Net sales for the three months ended June 30, 2026 rose 0.5% year over year to $1,692.3 million, while foreign currency translation added 0.9%, leaving organic revenue down 0.4%. Net income fell to $38.1 million from $64.7 million a year earlier, while adjusted net income was $143.3 million and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $254.3 million, for a 15.0% margin. Diluted GAAP EPS was $0.06 and adjusted EPS was $0.21. Operating cash flow was $178.2 million and free cash flow was $142.8 million, which the company said helped fund $112.1 million of debt repayment. Avantor now expects fiscal 2026 organic revenue growth of -0.5% to +0.5%, compared with prior guidance of -2.5% to -0.5%, and adjusted EPS of $0.80 to $0.83 versus $0.77 to $0.83 previously.